Phibro Animal Health | PAHC - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Align Technology USD 3.96B 44.68M 2025-09
ANI Pharmaceuticals USD 540.72M 34.91M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Canopy Growth CAD 758.17M 22.16M 2025-12
Corcept Therapeutics USD 647.8M 15.9M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Henry Schein USD 3.24B 116M 2025-12
Idexx Laboratories USD 1.61B 44.2M 2025-12
Knight Therapeutics CAD 767.27M 480K 2025-12
Merck USD 51.85B 2.79B 2025-09
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Pacira USD 693.11M 34.1M 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 1.83B 4.48M 2025-12
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
Zoetis USD 3.33B 2.07B 2025-12